|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Interest and dividend income | |||||
| Loans, including fees | |||||
| Taxable securities | |||||
| Tax-exempt securities | |||||
| Federal funds sold and other | |||||
| Total interest income | |||||
| Interest expense | |||||
| Deposits | |||||
| Other borrowings | |||||
| Federal funds purchased and repurchase agreements | |||||
| Federal Home Loan Bank advances | |||||
| Total other borrowings | |||||
| Long-term debt | |||||
| Subordinated debentures | |||||
| Total interest expense | |||||
| Net interest income | |||||
| Credit loss expense - loans | |||||
| Credit loss (benefit) expense - unfunded commitments | |||||
| Credit loss (benefit) expense - debt securities held-to-maturity | |||||
| Net interest income after credit loss expense | |||||
| Noninterest income | |||||
| Service charges and fees on deposit accounts | |||||
| Deposit Account | |||||
| Debit Card | |||||
| Gross gains on sales and calls of securities | |||||
| Net (loss) gain on sale of securities available-for-sale | |||||
| Net (loss) gain on sale of fixed assets | |||||
| Increase in cash surrender value of life insurance | |||||
| Realized losses on available-for-sale securities | |||||
| Realized gain (loss) on available-for-sale securities | |||||
| Other income | |||||
| Total noninterest income | |||||
| Noninterest expense | |||||
| Salaries and employee benefits | |||||
| Occupancy and equipment | |||||
| Other | |||||
| Total noninterest expense | |||||
| Income before taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Earnings per share | |||||
| Earnings per share, basic (in dollars per share) | |||||
| Earnings per share, diluted (in dollars per share) | |||||
| Weighted average shares outstanding, basic (in shares) | |||||
| Weighted average shares outstanding, diluted (in shares) |
Loading...